FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00- £194.51m
- £202.26m
Faron issues second tranche of bonds with an aggregated principal amount of EUR 10 million under its convertible bond arrangement
AnnouncementREG - AIM - AIM Notice - 05/12/2025
AnnouncementFaron Pharmaceuticals Ltd: Holding(s) in Company
AnnouncementFaron Pharmaceuticals Ltd: Registration of New Shares
AnnouncementFaron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First Tranche Bonds
AnnouncementFaron Pharmaceuticals Ltd: Grant of Options
AnnouncementFaron Pharmaceuticals Ltd: Appointment of CFO
AnnouncementFaron’s Financial Calendar for 2026
AnnouncementINSIDE INFORMATION: FARON INTENDS TO ISSUE SECOND TRANCHE OF BONDS WITH AN AGGREGATED PRINCIPAL AMOUNT OF EUR 10 MILLION UNDER ITS CONVERTIBLE BOND ARRANGEMENT
AnnouncementREG - AIM - AIM Notice - 29/10/2025
AnnouncementFaron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Advanced Amortisation of the First Tranche Bonds
AnnouncementFARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
AnnouncementUpdated BEXMAB Phase I/II Data presented at ESMO 2025 shows further improvement, strengthening the clinical profile of bexmarilimab in treatment-naïve HR-MDS patients
AnnouncementREG - AIM - AIM Notice - 10/10/2025
AnnouncementREG - AIM - AIM Notice - 06/10/2025
AnnouncementREG - AIM - AIM Notice - 04/06/2025
AnnouncementREG - Faron Pharma. Oy - FDA Grants Orphan Drug Designation
AnnouncementREG - Faron Pharma. Oy - Notice of Annual General Meeting
AnnouncementREG - Faron Pharma. Oy - Positive EMA Opinion on Orphan Drug Designation
Announcement